10,778 Shares in Astera Labs, Inc. $ALAB Purchased by VIRGINIA RETIREMENT SYSTEMS ET Al

VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 10,778 shares of the company’s stock, valued at approximately $5,206,000.

Other hedge funds have also added to or reduced their stakes in the company. Eurizon Capital SGR S.p.A. bought a new stake in shares of Astera Labs in the 4th quarter worth approximately $18,708,000. Swedbank AB grew its holdings in Astera Labs by 76.8% during the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after purchasing an additional 33,940 shares during the period. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new position in Astera Labs during the fourth quarter valued at $499,000. Revere Asset Management Inc purchased a new stake in Astera Labs in the fourth quarter worth $589,000. Finally, Banque Cantonale Vaudoise increased its position in Astera Labs by 85.9% in the first quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company’s stock worth $766,000 after buying an additional 3,229 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Insider Activity at Astera Labs

In related news, COO Sanjay Gajendra sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of the stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the completion of the sale, the director owned 3,970 shares in the company, valued at $1,237,965.10. This represents a 69.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 592,244 shares of company stock valued at $209,729,973 in the last quarter. 10.40% of the stock is currently owned by company insiders.

Astera Labs Stock Down 6.9%

Shares of NASDAQ ALAB opened at $288.85 on Wednesday. The company has a market cap of $50.11 billion, a P/E ratio of 143.00 and a beta of 3.77. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The business has a 50-day simple moving average of $323.95 and a two-hundred day simple moving average of $257.68.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. During the same period in the prior year, the business posted $0.44 earnings per share. The company’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities research analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have recently commented on ALAB. TD Cowen dropped their price target on Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research report on Wednesday, August 5th. Jefferies Financial Group boosted their price objective on Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Zacks Research raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. Needham & Company LLC increased their target price on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Finally, Royal Bank Of Canada lifted their target price on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $348.33.

Astera Labs Profile

Astera Labs, Inc is a semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect, expand and manage compute, memory, storage and networking resources in high-performance server systems.

The company’s product portfolio includes semiconductor-based connectivity solutions such as PCI Express (PCIe) and Compute Express Link (CXL) retimers, fabric switches and memory connectivity products.